RUBIN; Arkady

Patent Applications and Registrations

Patent applications and USPTO patent grants for RUBIN; Arkady.The latest application filed is for "oral combination drug formulation comprising a non-steroidal anti-inflammatory drug and a complementary low dose of tranexamic acid for the treatment of menstrual pain accompanied with excessive menstrual blood loss".

Company Profile

0.13.27

RUBIN; Arkady - Flemington NJ
Rubin, Arkady - Brooklyn NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Oral Combination Drug Formulation Comprising A Non-steroidal Anti-inflammatory Drug And A Complementary Low Dose Of Tranexamic Acid For The Treatment Of Menstrual Pain Accompanied With Excessive Menstrual Blood Loss App 20220257548 - RUBIN; Arkady	2022-08-18
Oral combination drug formulation comprising a non-steroidal anti-inflammatory drug and a complementary low dose of tranexamic acid for the treatment of menstrual pain accompanied with excessive menstrual blood loss Grant 11,351,132 - Rubin June 7, 2	2022-06-07
Treatment Of Endometriosis By Intravaginal Administration Of A Low Dose Of A Selective Progesterone Receptor Modulator (sprm), Anti-progestin, Or Anti-progestational Agent App 20210369606 - RUBIN; Arkady	2021-12-02
Multiphasic Contraceptive Regimen For Oral Combination Drug Formulation Of Progestin And Estrogen App 20210346397 - RUBIN; Arkady	2021-11-11
Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (SPRM), anti-progestin, or anti-progestational agent Grant 11,116,718 - Rubin September 14, 2	2021-09-14
Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen Grant 11,103,515 - Rubin August 31, 2	2021-08-31
Oral Combination Drug Formulation Comprising A Non-steroidal Anti-inflammatory Drug And A Complementary Low Dose Of Tranexamic Acid For The Treatment Of Menstrual Pain Accompanied With Excessive Menstrual Blood Loss App 20200330414 - RUBIN; Arkady	2020-10-22
Oral combination drug formulation comprising a non-steroidal anti-inflammatory drug and a complementary low dose of tranexamic acid for the treatment of menstrual pain accompanied with excessive menstrual blood loss Grant 10,709,679 - Rubin	2020-07-14
Multiphasic Contraceptive Regimen For Oral Combination Drug Formulation Of Progestin And Estrogen App 20200147105 - RUBIN; Arkady	2020-05-14
Oral Combination Drug Formulation Comprising A Non-steroidal Anti-inflammatory Drug And A Complementary Low Dose Of Tranexamic A App 20200093771 - RUBIN; Arkady	2020-03-26
Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen Grant 10,537,582 - Rubin Ja	2020-01-21
Oral combination drug formulation comprising a non-steroidal anti-inflammatory drug and a complementary low dose of tranexamic acid for the treatment of menstrual pain accompanied with excessive menstrual blood loss Grant 10,532,037 - Rubin Ja	2020-01-14
Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen Grant 10,463,678 - Rubin No	2019-11-05
Multiphasic Contraceptive Regimen For Oral Combination Drug Formulation Of Progestin And Estrogen App 20190282587 - RUBIN; Arkady	2019-09-19
Treatment Of Uterine Fibroids By Intravaginal Administration Of A Low Dose Of Selective Progesterone Receptor Modulator (sprm), App 20190201418 - RUBIN; Arkady	2019-07-04
Oral Combination Drug Formulation Comprising A Non-steroidal Anti-inflammatory Drug And A Complementary Low Dose Of Tranexamic A App 20190192460 - RUBIN; Arkady	2019-06-27
Treatment Of Endometriosis By Intravaginal Administration Of A Low Dose Of A Selective Progesterone Receptor Modulator (sprm), A App 20190175496 - RUBIN; Arkady	2019-06-13
Treatment Of Excessive Menstrual Blood Loss By Feminine Sanitary Products Medicated With Hemostatic Agent App 20190151634 - RUBIN; Arkady	2019-05-23
Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (SPRM), anti-progestin, or anti-progestational agent Grant 10,251,836 - Rubin	2019-04-09
Multiphasic Contraceptive Regimen For Oral Combination Drug Formulation Of Progestin And Estrogen App 20190022109 - RUBIN; Arkady	2019-01-24
Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen Grant 10,111,887 - Rubin October 30, 2	2018-10-30
Multiphasic Contraceptive Regimen For Oral Combination Drug Formulation Of Progestin And Estrogen App 20180207176 - RUBIN; Arkady	2018-07-26
Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen Grant 9,925,199 - Rubin March 27, 2	2018-03-27
Multiphasic Contraceptive Regimen For Oral Combination Drug Formulation Of Progestin And Estrogen App 20170246183 - RUBIN; Arkady	2017-08-31
Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen Grant 9,675,622 - Rubin June 13, 2	2017-06-13
Multiphasic Contraceptive Regimen For Oral Combination Drug Formulation Of Progestin And Estrogen App 20140296193 - RUBIN; Arkady	2014-10-02
Contraceptive Method App 20140256690 - RUBIN; Arkady ; et al.	2014-09-11
Oral Combination Drug Formulation Comprising A Non-steroidal Anti-inflammatory Drug And A Complementary Low Dose Of Tranexamic Acid For The Treatment Of Menstrual Pain Accompanied With Excessive Menstrual Blood Loss App 20140039054 - RUBIN; Arkady	2014-02-06
Treatment Of Menstrual Pain And Excessive Menstrual Blood Loss By Intravaginal Administration Of A Low Dose Of Antifibrinolytic Or Hemostatic Agent In Combination With Non-steroidal Anti-inflammatory Drug App 20140030313 - RUBIN; Arkady	2014-01-30
Treatment Of Endometriosis By Intravaginal Administration Of A Low Dose Of A Selective Progesterone Receptor Modulator (sprm), Anti-progestin, Or Anti-progestational Agent App 20140004171 - RUBIN; Arkady	2014-01-02
Treatment Of Uterine Fibroids By Intravaginal Administration Of A Low Dose Of Selective Progesterone Receptor Modulator (sprm), Anti-progestin, Or Anti-progestational App 20140005157 - RUBIN; Arkady	2014-01-02
Treatment Of Excessive Menstrual Blood Loss By Feminine Sanitary Products Medicated With Antifibrinolytic Or Hemostatic Agent App 20130345678 - RUBIN; Arkady	2013-12-26
Treatment Of Excessive Menstrual Blood Loss By Intravaginal Administration Of Low Doses Of Antifibrinolytic Or Hemostatic Agent App 20130337054 - RUBIN; Arkady	2013-12-19
Triphasic oral contraceptive App 20050038006 - Shangold, Gary A. ; et al.	2005-02-17
Triphasic oral contraceptive App 20010044429 - Shangold, Gary A. ; et al.	2001-11-22
Triphasic oral contraceptive Grant 6,214,815 - Shangold , et al. April 10, 2	2001-04-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.